Alterations in CD8αβ and CD8αα T Cell Levels in Patients With Rheumatoid Arthritis

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Rheumatoid Arthritis
Interventions
DIAGNOSTIC_TEST

flow cytometry

"Levels of circulating and synovial fluid CD4+ and CD4- T cells expressing CD8αα and CD8αβ will be assessed by flow cytometry using fluorochrome-labelled monoclonal antibodies against CD3, CD4, CD8α and CD8β surface markers. Levels of the following cells will be assessed:~1. CD3+CD4-CD8αα+~2. CD3+CD4-CD8α+CD8βlow~3. CD3+CD4-CD8α+CD8βhigh~4. CD3+CD4+CD8αβhigh~5. CD3+CD4+CD8αα+"

All Listed Sponsors
lead

Assiut University

OTHER

NCT05827562 - Alterations in CD8αβ and CD8αα T Cell Levels in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter